Northern Trust’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9K | Hold |
19,208
| – | – | ﹤0.01% | 4330 |
|
|
2025
Q1 | $24K | Hold |
19,208
| – | – | ﹤0.01% | 4322 |
|
|
2024
Q4 | $30.2K | Hold |
19,208
| – | – | ﹤0.01% | 4334 |
|
|
2024
Q3 | $36.7K | Hold |
19,208
| – | – | ﹤0.01% | 4259 |
|
|
2024
Q2 | $37.6K | Sell |
19,208
-21
| -0.1% | -$41 | ﹤0.01% | 4248 |
|
|
2024
Q1 | $45.6K | Sell |
19,229
-54
| -0.3% | -$128 | ﹤0.01% | 4238 |
|
|
2023
Q4 | $41.7K | Hold |
19,283
| – | – | ﹤0.01% | 4264 |
|
|
2023
Q3 | $40.5K | Sell |
19,283
-9,132
| -32% | -$19.2K | ﹤0.01% | 4218 |
|
|
2023
Q2 | $81.3K | Sell |
28,415
-833
| -3% | -$2.38K | ﹤0.01% | 4089 |
|
|
2023
Q1 | $85.1K | Sell |
29,248
-8,371
| -22% | -$24.4K | ﹤0.01% | 4117 |
|
|
2022
Q4 | $110K | Sell |
37,619
-11
| -0% | -$32 | ﹤0.01% | 4063 |
|
|
2022
Q3 | $90K | Hold |
37,630
| – | – | ﹤0.01% | 4145 |
|
|
2022
Q2 | $84K | Buy |
37,630
+1,989
| +6% | +$4.44K | ﹤0.01% | 4239 |
|
|
2022
Q1 | $82K | Buy |
35,641
+185
| +0.5% | +$426 | ﹤0.01% | 4411 |
|
|
2021
Q4 | $89K | Buy |
+35,456
| New | +$89K | ﹤0.01% | 4457 |
|